Cargando…

Drug Repurposing: a Shortcut to New Biological Entities

Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Nutan, Poojari, Tushar, Poojary, Charvi, Sande, Ruksar, Sawant, Sonal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734433/
https://www.ncbi.nlm.nih.gov/pubmed/36531825
http://dx.doi.org/10.1007/s11094-022-02778-w
_version_ 1784846583764877312
author Rao, Nutan
Poojari, Tushar
Poojary, Charvi
Sande, Ruksar
Sawant, Sonal
author_facet Rao, Nutan
Poojari, Tushar
Poojary, Charvi
Sande, Ruksar
Sawant, Sonal
author_sort Rao, Nutan
collection PubMed
description Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its advantages and the challenges faced during the process are the important factors to be considered in drug repurposing. The approaches in drug discovery include three methods namely computational, biological and mixed. Moreover, the recent advancement in application of drugs for COVID-19 proved drug repurposing is a vital strategy in medical science for the upcoming years.
format Online
Article
Text
id pubmed-9734433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97344332022-12-12 Drug Repurposing: a Shortcut to New Biological Entities Rao, Nutan Poojari, Tushar Poojary, Charvi Sande, Ruksar Sawant, Sonal Pharm Chem J Article Drug repurposing has proved to be an efficient alternative to drug discovery owing to the facts that it is economical and risk factors being much lower or even negligible as the drug has already been approved for having safe use in humans. The contrast of drug discovery from drug repurposing, its advantages and the challenges faced during the process are the important factors to be considered in drug repurposing. The approaches in drug discovery include three methods namely computational, biological and mixed. Moreover, the recent advancement in application of drugs for COVID-19 proved drug repurposing is a vital strategy in medical science for the upcoming years. Springer US 2022-12-07 2022 /pmc/articles/PMC9734433/ /pubmed/36531825 http://dx.doi.org/10.1007/s11094-022-02778-w Text en © Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Rao, Nutan
Poojari, Tushar
Poojary, Charvi
Sande, Ruksar
Sawant, Sonal
Drug Repurposing: a Shortcut to New Biological Entities
title Drug Repurposing: a Shortcut to New Biological Entities
title_full Drug Repurposing: a Shortcut to New Biological Entities
title_fullStr Drug Repurposing: a Shortcut to New Biological Entities
title_full_unstemmed Drug Repurposing: a Shortcut to New Biological Entities
title_short Drug Repurposing: a Shortcut to New Biological Entities
title_sort drug repurposing: a shortcut to new biological entities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734433/
https://www.ncbi.nlm.nih.gov/pubmed/36531825
http://dx.doi.org/10.1007/s11094-022-02778-w
work_keys_str_mv AT raonutan drugrepurposingashortcuttonewbiologicalentities
AT poojaritushar drugrepurposingashortcuttonewbiologicalentities
AT poojarycharvi drugrepurposingashortcuttonewbiologicalentities
AT sanderuksar drugrepurposingashortcuttonewbiologicalentities
AT sawantsonal drugrepurposingashortcuttonewbiologicalentities